SIStockInvestingSI.com

NASDAQ · TECH · Biotechnology

Bio-Techne Corp (TECH) stock analysis

$72.64+0.08%Data as of Oct 21, 2026
  • TECH gained 0.1% over the past month versus 0.0% for the S&P 500, ranking 314th of 497 S&P 500 stocks.
  • Over 12 months it returned +16.5%, 0.7 points ahead of the S&P 500, and trades 0.0% below its 52-week high.
  • In the last 30 days 3 analysts raised earnings estimates and 0 cut; forward EPS moved +0.3% (+0.5% over 90 days).
  • It sits in the Laboratory & analytical tools segment of the Medtech, Diagnostics & Care, where the 1-month median return is +6.4%.
  • The daily chart reads Intermediate uptrend · Trend advance (since Oct 21, 2026).
Market cap$11.4B
12-month return+16.5%
Forward P/E31.5×
Mean target vs price−2.6%

One-year price with 50- and 200-day averages

Open in Hub
45.653.962.170.3JanAprJulOct
72.6450-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

TECH+0.1%
Sector median−8.7%
S&P 5000.0%
TECH+1.2%
Sector median−5.4%
S&P 500+4.7%
TECH+24.0%
Sector median−1.5%
S&P 500+8.7%
TECH+16.5%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500314 / 497
3-month rank in its sector · Healthcare297 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Intermediate uptrend · Trend advanceConfirmed

Holding since Oct 21, 2026

  • Close above EMA20 above EMA50
  • EMA50 rose over the last ten sessions
This pattern on this stock

76 occurrences in 10 years. The median move over the next 20 sessions was 0.0%, positive 50% of the time, against +0.8% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$2.31
30-day change+0.3%
90-day change+0.5%
Mean target$70.73 −2.6%
Raised (30d) 3Cut (30d) 0

11 analysts cover the stock

Where it sits in the supply chain

Medtech, Diagnostics & Care · Tools & research

Explore the full chain map in Hub
Its segment
Laboratory & analytical tools+6.4%
TMO+5.4%1 monthDHR+6.0%1 monthA+6.4%1 monthWAT+7.5%1 monthMTD+12.6%1 monthRVTY+9.3%1 monthTECH+0.1%1 month

Instruments and reagents serve research and labs; budgets and inventories affect orders.

Sells into
Clinical laboratory services+3.0%
LH+3.9%1 monthDGX+2.2%1 month
Research & clinical outsourcing+11.7%
CRL+21.0%1 monthIQV+2.4%1 month

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−39.4%
Volatility, 60D2.6%
From 52-week high0.0%
From 52-week low+68.1%
Trailing P/E62.6×
Forward P/E31.5×

Themes

  • Biotech Platform3M rank 120 / 414
TMOThermo Fisher ScientificDHRDanaherAAgilent Technologies, Inc.WATWaters CorporationMTDMettler-Toledo International, IRVTYRevvity, Inc.LHLabcorp Holdings Inc.DGXQuest Diagnostics Incorporated

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗